英派药业-B(07630.HK)预期中期取得亏损约8170万元至9990万元 同比减少约22%至37%

智通财经
Aug 11
【英派药业-B(07630.HK)预期中期取得亏损约8170万元至9990万元 同比减少约22%至37%】智通财经APP讯,英派药业-B(07630.HK)发布公告,根据董事会对本集团截至2026年6月30日止6个月(相关期间)未经审核综合管理账目的初步评估及董事会目前可得资料,本集团预期于相关期间取得:收入约人民币9470万元至人民币1.16亿元,较截至2025年6月30日止6个月(同期)约人民币2520万元增加约276%至359%;期内亏损约人民币8170万元至人民币9990万元,较同期约人民币1.29亿元减少约37%至22%。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10